| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1769.41 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 1309.64 | 97 |
| GSM780709 | Untreated after 4 days (C3_1) | 938.963 | 95 |
| GSM780719 | Untreated after 4 days (C1_2) | 1834.46 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 1323.7 | 97 |
| GSM780721 | Untreated after 4 days (C3_2) | 932.624 | 95 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2737.74 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 798.416 | 94 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 5106.07 | 99 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 2644.09 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 764.889 | 94 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 5697.78 | 99 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 710.357 | 94 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2296.34 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1207.42 | 96 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 681.763 | 94 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 2316.93 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1264.76 | 96 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 660.028 | 93 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 850.414 | 95 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1045.79 | 96 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 703.887 | 94 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 947.256 | 95 |